Plasma Exchange in Acute on Chronic Liver Failure
Therapeutic Plasma Exchange in Patients With Acute on Chronic Liver Failure: A Randomized Controlled Trial (PLEXAR)
Sponsor: Asian Institute of Gastroenterology, India
This PHASE3 trial investigates Acute-On-Chronic Liver Failure and Cirrhosis, Liver and is currently ongoing. Asian Institute of Gastroenterology, India leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2019 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Aug 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Asian Institute of Gastroenterology, India
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.